Since graduating with a PhD in biochemistry from Queen’s University Belfast, Andrew has attained over 10 years’ experience in the design, implementation and tech-transfer of processes for the manufacture of biocatalysts, small molecule APIs and biologics. Andrew now holds a commercial role as Associate Director, Scientific Solutions within Charles River CDMO Services with a focus on plasmid DNA and gene therapy manufacturing.